1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 06 APRIL 2015

Cancer Drug News 06 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Kyprolis Unlikely To Rival Pomalyst Despite Priority Review
Industry Brief - CASI Initiates ENMD-2076 Phase II Trial For TNBC In China
Industry Brief - Medigene Initiates Phase I/II Study With Dendritic Cell Vaccine For AML
Industry Brief - Pracinostat/Azacitidine Combination Misses Primary Endpoint Phase II MDS Trial
Industry Trend Analysis - Loss Of Celgene Partnership Will Be A Temporary Setback For MorphoSys
Industry Brief - Iclusig Gains Marketing Approval In Israel
Industry Trend Analysis - Infinity/AbbVie's Actions Indicate Confidence In Duvelisib's Future Success
Industry Brief - Immunovaccine Initiates Phase II Study Of DPX-Survivac In Recurrent DLBCL
Industry Brief - DSMB Recommends Continuation Of Lirilumab Phase II Trial With Two Arms
Industry Brief - Velcade Approved In UK For First-Line MCL
Industry Brief - FDA Grants ODD To Idera's IMO-8400 For DLBCL
Industry Trend Analysis - Failing Phase II Trial Will Not Deter ASONEP's Development
Industry Brief - FDA Approves Zytiga Label Update
Industry Brief - CASI Receives CFDA Approval For ENMD-2076 Phase II Trial In OCCC
Industry Brief - Oncolytics' Reolysin Gains EU Orphan Designation For Gynaecological Cancers
Industry Trend Analysis - Personalised Medicine Leading To Fewer Drugs Being Shelved
Industry Brief - Lexicon/Ipsen Expand Telotristat Etiprate Licensing Deal To Include Canada
Industry Brief - Fruquintinib Phase II PoC Study Meets Primary Endpoint In MCRC
Industry Brief - VBL's VB-111 Significantly Improves OS In Phase II Trial For rGBM
Industry Trend Analysis - BMS/Merck Still Battling For Melanoma Market Share
Industry Brief - Eisai's Lenvima Approved In Japan For Unresectable TC
Industry Brief - Eisai's Lenvima Gains CHMP Positive Opinion For RAI-R DTC
Industry Trend Analysis - Takeda's Success In ADCs Relies On Multiple Agreements
Industry Brief - GenVec/TheraBiologics To Co-Develop NSC-Mediated Cancer Therapies
Industry Brief - Teikoku Submits NDA For Docetaxel Injection Concentrate Non-Alcohol Formula
Industry Trend Analysis - Merck Collaboration Confirms Bright Future For Syndax
Industry Brief - BioInvent/CRT Expand Collaboration With University Of Southampton For Cancer Immunotherapies
Industry Brief - Intrexon/NCI Sign CRADA To Develop Cancer Therapies Using RTS Platform
Industry Brief - Sunshine Biopharma Granted Indian Patent Allowance Covering Adva-27a
Industry Brief - FDA Grants ODD To Aduro's CRS-207 For Mesothelioma
Industry Trend Analysis - Aduro's IPO To Benefit From Novartis Deal
Industry Brief - RedHill Acquires Phase II First-in-Class Oral SK2 Inhibitor From Apogee
Industry Brief - Helsinn Receives Positive CHMP Opinion On Akynzeo For CINV Prevention
Industry Brief - Helsinn/Mundipharma Sign Anamorelin Licensing Deal In Multiple Territories
Industry Trend Analysis - CAR-T Space Sees High Investment Despite High-Risk Environment
Industry Trend Analysis - High Investment In Onco-Immunotherapy Will Continue To Fuel IPO Trend
Industry Brief - Rigontec Raises Funds To Advance RNA-Based Immunotherapeutics For Cancer/Viral Diseases

Table Of Contents

Cancer Drug News 06 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.